IRS
NVO

Invictus RG (Singapore)’s Novo Nordisk NVO Stock Holding History

Invictus RG (Singapore)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-818
Closed -$22K – 299
2015
Q3 		$22K Buy
818
+508
+164% +$14.4K 0.02% 469
2015
Q2 		$8K Buy
+310
New +$8.71K 0.01% 583
2015
Q1 		– Sell
-466
Closed -$10K – 662
2014
Q4 		$10K Buy
466
+118
+34% +$2.64K 0.01% 559
2014
Q3 		$8K Sell
348
-2,122
-86% -$48.8K 0.01% 581
2014
Q2 		$57K Buy
2,470
+1,646
+200% +$36.3K 0.06% 380
2014
Q1 		$19K Buy
+824
New +$17.6K 0.02% 497

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Invictus RG (Singapore)'s NVO Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Novo Nordisk (NVO) in Q4 2015, closing a stake of 818 shares — an estimated $22K sold.

Invictus RG (Singapore) first reported a position in NVO in Q1 2014 and held it in 6 quarters. The position peaked at $57K in Q2 2014. 549 funds tracked by Wall St. Rank hold NVO as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Novo Nordisk position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 818 Novo Nordisk shares in Q4 2015, an estimated $22K.
  • Invictus RG (Singapore) first reported a position in Novo Nordisk in Q1 2014 and held it in 6 quarters.
  • Invictus RG (Singapore)'s Novo Nordisk position peaked at $57K in Q2 2014.
  • 549 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.